Research Catalog

Recombinant bovine growth hormone FDA approval should be withheld until the mastitis issue is resolved : report to congressional requesters

Title
Recombinant bovine growth hormone [microform] : FDA approval should be withheld until the mastitis issue is resolved : report to congressional requesters / United States General Accounting Office.
Author
United States. General Accounting Office.
Publication
Washington, D.C. : The Office ; Gaithersburg, MD (P.O. Box 6015, Gaithersburg 20884-6015) : The Office [distributor, 1992]

Details

Description
64 p.; 28 cm.
Alternative Title
FDA approval should be withheld until the mastitis issue is resolved.
Subject
  • United States. Food and Drug Administration > Auditing
  • Bovine somatotropin > Research > Evaluation. > United States
  • Mastitis > United States > Chemotherapy
  • Milk contamination > United States
Note
  • Cover title.
  • Distributed to depository libraries in microfiche.
  • Shipping list no.: 93-0069-M.
  • "August 1992."
  • "GAO/PEMD-92-26."
  • "B-248450"--P. 1.
Bibliography (note)
  • Includes bibliographical references.
Reproduction (note)
  • Microfiche.
Call Number
READEX Microfiche GA 1.13:PEMD-92-26
OCLC
marcive27996059
Author
United States. General Accounting Office.
Title
Recombinant bovine growth hormone [microform] : FDA approval should be withheld until the mastitis issue is resolved : report to congressional requesters / United States General Accounting Office.
Imprint
Washington, D.C. : The Office ; Gaithersburg, MD (P.O. Box 6015, Gaithersburg 20884-6015) : The Office [distributor, 1992]
Bibliography
Includes bibliographical references.
Reproduction
Microfiche. [Washington, D.C.] : U.S. General Accounting Office, [1993?] 1 microfiche : negative.
Gpo Item No.
0546-D (MF)
Sudoc No.
GA 1.13:PEMD-92-26
Research Call Number
READEX Microfiche GA 1.13:PEMD-92-26
View in Legacy Catalog